YouTube Facebook LinkedIn Google+ Twitter Xingrss  

Biotech's Takeover Protection Thanks to a Few Big Investors


May 3, 2012 | Biotech's ability to fight off Big Pharma is due to a handful of large investors that dominate the companies' shares registries. Of 10 likely biotech takeover targets, four investment companies have majority shares. Reuters
Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

For reprints and/or copyright permission, please contact  Jay Mulhern, (781) 972-1359, jmulhern@healthtech.com.